ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year

February 5, 1993

In Brief: NIH Funding For Shannon Awards To Fall, Eight Institutes Decide Not To Participate

August 13, 1993

Mass. Congressman Pressed For $1.5 M Proton Beam Funds

August 18, 1989

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

NCI Resources, Services Available For Cancer Research

June 7, 1996

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990